Methicillin-Resistant Staphylococcus Aureus (MRSA) in a Portuguese hospital and its risk perception by health care professionals  by Peres, David et al.
www.elsevier.pt/rpsp
Temas nesta Revista
Editorial – A crise e a saúde pública
Custos indirectos da dor crónica
Utilização do SF-6D na medição das preferências 
dos portugueses
Efeitos adversos na prestação de cuidados 
hospitalares em Portugal no ano de 2008
Etiologia e sensibilidade bacteriana em infecções 
do tracto urinário
Methicillin-Resistant Staphylococcus aureus (MRSA) 
in a Portuguese hospital and its risk perception by 
health care professionals
Associação entre os sintomas da disfunção temporo-
mandibular com factores psicológicos e alterações 
na coluna cervical em alunos da ESSJP-Algarve
Análise comparativa de métodos de abordagem 
da obesidade infantil
Satisfação pro¿ ssional dos enfermeiros em cuidados 
de saúde primários
Grau de conhecimento e consumo de psicofármacos 
dos alunos da ESTSC
Associação entre o marketing de produtos alimentares 
de elevada densidade energética e a obesidade infantil
Comparação dos utentes do antigo Hospital do 
Desterro com os utentes do Hospital de S. José no 
acesso à consulta de Medicina Interna - Parte I
saúde
pública
 
 
 R
ev
is
ta
po
rtu
gu
es
a d
e
pu
bl
ic
aç
ão
 s
em
es
tr
al
Julho-Dezembro2011
ISSN 0870-9025
0870-9025X/$ - ver introdução © 2010 Escola Nacional de Saúde Pública. Publicado por Elsevier España, S.L. Todos os direitos reservados.
Rev Port Saúde Pública. 2011;29(2):132-139
Artigo original
Methicillin-Resistant Staphylococcus Aureus (MRSA) 
in a Portuguese hospital and its risk perception 
by health care professionals
David Peresa,b, Elaine Pinac e Margarida Fonseca Cardosod,e,f,*
aInfection Control Unit, Hospital Pedro Hispano, Matosinhos, Portugal
bGrupo Coordenador Regional de Controlo de Infecção, Administração Regional de Saúde do Norte, Porto, Portugal
cPrograma Nacional de Controlo de Infecção, Direcção-Geral da Saúde, Lisboa, Portugal
dICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
eCIIMAR - Centro Interdisciplinar de Investigação Marinha e Ambiental, Porto, Portugal
fISPUP - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
ARTICLE INFO
Article history:
Received 5 November 2010
Accepted 12 May 2011
Keywords: 
MRSA
Infection control
Risk perception
Portugal
* Corresponding author.  
E-mail address: mcard@icbas.up.pt (M. Fonseca Cardoso).
A B S T R A C T
Objective: To describe the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) 
and to assess its perception by healthcare professionals.
Design: Survey, through a two-part questionnaire.
Setting: A 441-bed district general hospital.
Participants: Part I - Inpatients over 16 years of age, in whom a non-nasal MRSA was isolated 
between February and August of 2005. Part II - nurses and doctors responsible for these patients. 
Methods: Part I – Demographic and clinical data collected from medical notes. Part II – 
Perception of doctors and nurses. Observed agreement and “Kappa” statistic were used to 
compare perceptions. A P value lower than 0.05 was considered to be statistically significant.
Results: Of the 111  patients identified, 50.9% had history of hospitalization during the 
previous year, with high exposure to antimicrobial therapy and invasive procedures. 
Hospital stay was 4.5  times higher than the average inpatients and mortality 5.5  times 
higher. Proportion of MRSA was 60.0%, with an incidence density of 1.66%.
 Although agreement between nurses and doctors was low, the majority admitted 
nosocomial origin of the MRSA and its transmission through the hands of professionals. 
Reinforcement of hand hygiene was considered important to manage these patients by 
69.4% of nurses and 64.9% of doctors. Additionally, all nurses and 89.4% of doctors agreed 
on the need to isolate these patients. 
Conclusions: High endemic level of MRSA detected in a susceptible population, associated 
with a lower awareness of management of these patients by doctors, compared with 
nurses, justifies a global programme to control MRSA. This programme should include 
consensus-based measures for management of patients, rational use of antimicrobials, 
and dynamic and focused educational programmes. 
© 2010 Published by Elsevier España, S. L. on behalf of Escola Nacional de Saúde Pública. 
All rights reserved.
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Staphylococcus Aureus Resistente à Meticilina (MRSA) num hospital 
distrital do Grande Porto e percepção do risco pelos profissionais 
de saúde 
R E S U M O
Objectivo: Descrever e analisar a epidemiologia do Staphyloccocus aureus resistente à 
meticilina (MRSA) num hospital distrital de 441  camas do Grande Porto, bem como a 
percepção que enfermeiros e médicos têm do problema. 
Desenho do estudo: Estudo transversal descritivo, através da aplicação de um inquérito de 
duas partes. 
Definição: Um hospital distrital de 441 camas.
Participantes: Parte I - doentes internados com mais de 16 anos em que foi detectado MRSA 
não nasal, entre Fevereiro e Agosto de 2005. Parte II – enfermeiros e médicos responsáveis 
pela prestação de cuidados aos referidos doentes. 
Métodos: Parte I - recolha de dados demográficos, clínicos e factores de risco dos processos 
dos doentes. Parte II - aplicação de um inquérito a enfermeiros e médicos para análise 
das suas percepções. O acordo observado e a estatística “Kappa” foram utilizados para 
comparar as respostas entre classes de profissionais. O nível de significância adoptado foi 
de 5%. 
Resultados: Dos 111  casos estudados, 50,9% tinham historial de internamentos até há 
um ano atrás e 83,8% haviam estado expostos a antibioticoterapia prévia. O tempo de 
internamento foi 4,5 vezes maior que a média da população internada neste hospital, e a 
mortalidade 5,5 vezes maior. 
 A prevalência de MRSA foi de 60,0% e a densidade de incidência de 1,66 casos por mil 
dias de internamento. A grande maioria dos profissionais admite que o MRSA é adquirido 
no ambiente hospitalar e que são as mãos dos profissionais de saúde a principal via de 
transmissão. Como medidas para gerir doentes com MRSA, 69,4% dos enfermeiros e 64,9% 
dos médicos referem o reforço da higienização das mãos, a totalidade dos enfermeiros e 
89,4% dos médicos concordam com a necessidade de algum tipo de medidas de isolamento. 
Conclusões: Constatou-se a existência de altos valores endémicos de MRSA. Os profissionais 
têm a percepção da associação do MRSA aos cuidados de saúde, bem como a importância 
das mãos dos profissionais como veículo de transmissão, no entanto a classe médica está 
menos sensibilizada para as medidas de gestão para estes doentes. Parece justificar-se um 
programa global para controlo deste microrganismo, na gestão de doentes colonizados ou 
infectados por MRSA, na utilização racional dos antibióticos, bem como a formação dos 
profissionais de saúde, com um carácter mais dinâmico e dirigido.
© 2010 Publicado por Elsevier España, S. L. em nome da Escola Nacional de Saúde Pública. 
Todos os direitos reservados.
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Introduction
Staphylococcus aureus is a Gram-positive bacterium that 
colonizes the skin of about 30% of healthy humans, 
although mainly a harmless coloniser, S. aureus can cause 
severe infection. Its oxacillin-resistant form (Methicillin-
Resistant S. aureus, MRSA) is the most important cause 
of antibiotic-resistant healthcare-associated infections 
worldwide.1 Of the expected 2 billion individuals carrying 
S. aureus worldwide, conservative estimates, based on 
either Dutch or United States of America (USA) prevalence 
figures, would predict that between 2 million and 53 million 
carry MRSA.2 There are several studies which conclude that 
nosocomial MRSA infection increases morbidity, mortality, 
length of stay and costs.3-7 Historically, MRSA isolates have 
been associated with nosocomial infections, however, in 
recent years, different strains with unique phenotypes 
have emerged in the community, and the reservoir of 
this community-associated MRSA (CA-MRSA) is rapidly 
expanding.8 Mathematical models have shown that CA-MRSA 
has a high potential to become endemic in the community, 
and this will impact significantly on the control of MRSA in 
the hospital setting.9
For healthcare facilities, surveillance is an important and 
approved method to assess the incidence of infection due to 
multidrug-resistant bacteria and to improve infection control 
measures, if necessary.10 Various protocols and guidelines have 
been developed in an attempt to prevent the development 
and slow down in the transmission of nosocomial MRSA. If 
healthcare professionals (HCP’s) are to be successful in this 
objective, then understanding the epidemiology, pathogenesis 
and routes of transmission of MRSA in healthcare facilities 
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becomes critically important.11 In this study we describe the 
epidemiologic characteristics of the MRSA in a Portuguese 
district general hospital, as well as its perception by the HCP’s.
Methods
Study setting and infection control practices
This study was conducted at Pedro Hispano Hospital, a district 
general hospital in the north of Portugal with 441 beds. 
This facility, that serves a population of approximately 
430,000, is part of a “local healthcare unit”, which integrates 
the management of primary healthcare resources of the 
city of Matosinhos. Information about multirresistant 
microorganisms, including the MRSA (which is endemic in 
this facility) is available annually.
All patients with results positive for MRSA were treated 
with contact isolation measures, as recommended by the local 
infection control manual, based on the “Center for Disease 
Control and Prevention” (CDC) guidelines available at the time 
of the study.12 Intensive care patients of both existing units 
were screened for nasal colonization at admission and every 
4 days and, if positive for MRSA, decolonization was attempted 
with topical agents (nasal mupirocin and chlorhexidine 
bathing). 
Participants and data collection
Between February 21 and August 31, 2005 (192 days), the 
prospective infection surveillance system, based on laboratory 
results, identified all cultures positive for MRSA. Patients were 
excluded from the study if they: (a) were less than 16 years old, 
(b) had only nasal colonization detected, (c) had died or been 
discharged when the result was known or (d) were treated 
in ambulatory care. A two part questionnaire was applied to 
the 111 cases who met the criteria, after it was pretested and 
approved by the institutional ethics board.
In the first part, the investigators recovered demographic 
and clinical data from the medical record of each patient and, 
in the second part, the questionnaire was administered to the 
doctors and nurses responsible for this patient, in order to 
assess their perception of the epidemiology of MRSA (meaning 
of the strain identified, source and route of transmission) as 
well as the proper conduct to be followed to take care of this 
patient.
Definitions and terms
The risk factors associated with the use of indwelling devices 
(peripheral and central vascular catheters, urinary catheter, 
gastrointestinal tube, wound drainage device, endotracheal 
tube or tracheostoma and hemodialysis) were considered 
if they were present during the last 4 days, exposure to 
antibiotics during the last 7 days and, in case of a surgical 
procedure, during the last 30 days before the recovery of the 
sample which detected the MRSA.
“Immunodeficiency” was considered when the patient had 
any immunological disease or immunosuppressive therapy 
(chemotherapy, radiotherapy or steroids) in high doses during 
at least 15 days before the recovery of the sample which 
detected the MRSA.13 
The terms “single-room isolation” (isolation of patients in 
a single-bedded room), “cohorting” (physical segregation of 
a group of patients with MRSA from the other patients in a 
geographically distinct area of the same ward) and “barrier 
nursing” (use of aprons or gowns, gloves and, in some cases 
masks, by the HCP as the only physical barrier to transmission) 
were used to refer to the level of isolation, as recommended by 
an extensive systematic review on isolation policies.14
“Morbidity” estimation was based on the indicators 
proposed by Ducel et al.15 and Horan and Gaynes16, MRSA 
rates, using three different denominators: proportion of MRSA 
(percentage of strains resistant to methicillin within the total 
of S. aureus identified), the incidence (number of MRSA per 
1,000 admissions) and incidence density (number of MRSA 
per 1,000 patient-days).
Microbiological methods
Isolates were grown on blood and chocolate agar and confirmed 
as S. aureus by colony morphology, Gram stain, catalase test 
and through the rapid method “Staph aureus fumouze” 
(Fumouze Diagnostics, Paris, France). The antimicrobial 
susceptibility testing was determined by the automatic system 
“Vitek 2” (bioMérieux, Marcy l’Etoile, France). In case of doubt, 
confirmation of the minimum inhibitory concentration result 
was performed through “E-test” (AB Biodisk, Solna, Sweden). 
Strains with minimum inhibitory concentrations of 4 μg/mL 
of oxacillin or greater were considered resistant and 2 μg/mL 
or less, sensitive, according to the “Clinical and Laboratory 
Standards Institute” guidelines.17
Statistical analysis
Statistical analysis was performed using the “Statistical Package 
for the Social Sciences” (SPSS Inc., Chicago, USA) version 13.0. 
Categorical variables were compared using the chi-square or 
Fisher’s exact test. To evaluate agreement between doctors 
and nurses, responsible for each patient, observed agreement 
and the “Kappa” statistic were applied. “Kappa” statistic was 
assessed to quantify the extent of agreement beyond chance 
achieved by the two groups of HCP’s considered. The level of 
significance adopted was 5%.
Results
Demographic characteristics and risk factors
During the 192 day study period, 111 cases were detected. 
The demographic characteristics of these are listed in 
table 1. The male gender predominated (60.4% of the studied 
population) and almost half (47.8%) were between 60 and 
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79 years old. The majority of the patients came from the 
community (77.5%), but 17 of them (12.6%) were transferred 
from other hospitals and 8 (7.2%) from long-term care facilities.
According to table 2, more than half (50.9%) of the patients 
had a history of hospitalization during the previous year and 
almost 10% had previously been detected with MRSA. The 
majority of cases were identified in medical specialities (38.7%) 
followed by surgical (19.8%) and intermediate/intensive care 
department (16.2%). However it should be taken into account 
that 28.8% of the patients had been transferred from another 
ward, before the one where the MRSA was identified. A vast 
majority (83.8%) were exposed to antimicrobial therapy during 
the week before, with quinolones in 35.5% of the cases and 
cephalosporins in 29.0%. With respect to the risk factors 
associated with invasive procedures, 82.0% had a peripheral 
venous catheter and 51.4% an urinary catheter. Almost half 
(48.6%) had been subjected to a surgical procedure in the last 
thirty days and 17.1% had a central vascular catheter.
Morbidity and mortality
As listed in table 3, the mean length of stay was 40.7 days 
(median 31.5; range 5-182) with 20 patients (18.0%) who stayed 
more than 60 days.
More than one quarter of the studied population (27.0%) 
died in the hospital and 8 (7.2%) were transferred to other 
healthcare facilities. In 72.1% of the patients the MRSA 
was detected 48  hours after admission. The proportion 
of MRSA detected was 60.0%, the incidence was 11.9 per 
1,000 admissions and incidence density revealed 1.66 cases 
per 1,000 patient-days.
Perception of the healthcare professionals
Table 4  shows the perception of the HCP’s about the 
epidemiology of the MRSA, as well as the measures considered 
adequate to manage patients with positive cultures. More than 
70% of the doctors and nurses considered the identified strains 
as hospital acquired infections, however, in the remaining 
cases, nurses referred twice as frequently as the doctors that 
the strains could be community acquired. For this question, the 
observed agreement was 74.2% and the Kappa value of 0.336, 
which corresponds to a “fair agreement” between observers.18
For the second question (perception about the source of 
the strain), 44.2% of the nurses answered the “environment”, 
followed by 28.4% of these professionals who thought 
Characteristic N (%)
Gender
 Female 44 (39.6)
 Male 67 (60.4)
Age (years)
 20-39 13 (11.7)
 40-59 21 (18.9)
 60-79 53 (47.8)
 ≥80 24 (21.6)
Origin
 Community 86 (77.5)
 Acute care facility 17 (15.3)
 Long-term care facility  8 (7.2)
Table 1 – Demographic characteristics of the studied 
population (n=111)
 N (%)
General
 Hospitalization history (< 1 year) 58 (50.9a)
 MRSA history 6 (9.5b)
 Department of diagnosis
  Medical 43 (38.7)
  Surgical 22 (19.8)
  Intermediate/ Intensive care 18 (16.2)
 Transfer from other department 32 (28.8)
 Antibiotic exposure (total) 93 (83.8)
  Quinolones 33 (35.5c)
  Cephalosporins 27 (29.0c)
  Macrolides 5 (5.4c)
 Immunodeficiency 14 (12.6)
Invasive Procedure Associated
 Peripheral vascular catheter 91 (82.0)
 Central vascular catheter 19 (17.1)
 Urinary catheter 57 (51.4)
 Gastrointestinal tube 34 (30.6)
 Wound drainage device 15 (13.5)
 Endotracheal tube 13 (11.7)
 Tracheostoma 6 (5.4)
 Previous surgery (< 30 days) 54 (48.6)
 Hemodialysis 7 (6.3)
 an=106 / bn=63 / cn=93.
Table 2 – Risk factors present in the studied population 
(n=111)
Data N (%)
Length of stay
 Mean (days) 40.7
 ≤ 14  15 (13.5)
 15-29  37 (33.3)
 30-59  39 (35.2)
 ≥ 60  20 (18.0)
Type of discharge
 Home 73 (65.8)
 Other hospital 8 (7.2)
 Died 30 (27.0)
MRSA detection
 ≤ 48 hours 31 (27.9)
 > 48 hours 80 (72.1)
MRSA rates
 Proportion* 60.0 %
 Incidence 11.9 ‰
 Incidence density 1.66 ‰
 *The proportion value is based on the CLSI definition “first isolate 
per patient”17, considering the exclusion criteria of this study.
Table 3 – Morbidity and mortality in the studied 
population: general and MRSA specific (n=111)
136 Rev Port Saúde Pública. 2011;29(2):132-139
the source was a HCP. More doctors (39.8%) agreed to the 
hypothesis of the source being a HCP, 25.8% chose the 
option “own patient” and 18 doctors (19.4%) answered the 
“environment”. For this question the observed agreement 
was low (22.5%) and the Kappa value (-0.045) compatible to “by 
chance” agreement between these two groups of professionals.
For the perception of the route of transmission, more than 
half of both nurses and doctors referred the hands as the main 
route (60.4 and 62.9%, respectively). Within this category, it 
was the “hands of a HCP” which was indicated most frequently 
(61.8% of nurses and 66.1% of the doctors). The second 
option was “airborne” for nurses (22.0%) and “contaminated 
instrument” for doctors (21.3%). The observed agreement was 
45.8% and the Kappa value (0.004) was, again, compatible to 
“by chance” agreement.
When asked about the conduct to be followed for the care 
of MRSA positive patients, two (2.1%) doctors answered “none 
specifically”. The response “reinforce hand hygiene” was 
chosen by almost 70% of the nurses and by 64.9% of the doctors. 
All the nurses (100%) and 89.4% of the doctors agreed that the 
patient needed some type of isolation. Within this category, 
the first option was “barrier nursing” (79.6% of the nurses and 
72.6% of the doctors) followed by single-room isolation (13.3% 
and 15.5%, respectively). The need to alter/implement antibiotic 
therapy was assumed by 66 doctors (70.2%).
Discussion and conclusions
More than half of the studied sample had a history of 
hospitalization during the previous year and almost 10% had 
been previously diagnosed with MRSA, similarly to the 14.4% 
found by a study conducted in two terciary-care centers in 
Saudi Arabia.19
Interestingly, in the present study we found that it was 
in the medical department where most cases were detected, 
followed by surgical wards and intermediate/intensive care 
units, in contrast to other studies where the intensive 
care units (ICU) were in the first place.19-21 This difference 
could be explained by the aggressive strategy to control the 
MRSA in both ICU’s of this hospital (we are not aware if this 
occurred in the other studies). This information should be 
interpreted carefully, considering the exclusion criteria of 
this study, namely the fact that patients who had died when 
the result was known were not studied, since this could have 
had an influence in the number of critical patients included. 
Other sources of bias could be the different ratios ICU/general 
beds in the hospitals studied and the mobility of the patients 
within the facilities: we identified that 28.8% of the patients 
had been in other wards before the one where the MRSA was 
identified. A Spanish study detected an even higher value: 
37.8% in patients with bacteraemia by MRSA.22
Monnet et al.23 described several studies which conclude 
that exposure to cephalosporins, quinolones and macrolides 
constitutes risk factors for colonization or infection by MRSA. 
Similarly to our investigation, two other studies20,22 detected an 
exposure to antibiotics of over 70% in a population with MRSA 
and, in another hospital, around 66%.24 In contrast with the 
35.5% described by us, a 640 bed USA hospital study25 identified 
an exposure of 67.6% of MRSA positive patients to quinolones.
With the respect to the risk factors associated with invasive 
procedures, Montesinos et al.20 likewise detected a similar 
proportion of patients with intravascular catheter (79%) and 
subjected to a previous surgical intervention (51%) but a higher 
exposure to urinary catheters (77%). In a Swiss study,24 45.7% 
of the MRSA colonized patients had a not specified indwelling 
device and 54.3% a history of surgery in the last thirty days. 
The length of stay of the studied individuals was 4.5 times 
higher when compared to the general adult hospitalized 
population in this hospital (40.7 versus 9.0 days). This value 
Question Nurses
N (%)
Doctors
N (%)
What do you think is the meaning 
of the identification of this strain? 
Observed Agreement: 74.2% K=0.336 (p<0.001)
Colonization 11 (11.2) 14 (14.9)
Hospital acquired infection 71 (72.5) 73 (77.7)
Community acquired infection 16 (16.3)  7 (7.4)
TOTAL 98 (100.0) 94 (100.0)
What do you think was 
the source of this strain? 
Observed Agreement: 22.5% K=–0.045 (p=0.45)
Other patient 12 (12.6) 14 (15.0)
Own patient 14 (14.8) 24 (25.8)
Healthcare professional (HCP) 27 (28.4) 37 (39.8)
Environment 42 (44.2) 18 (19.4)
TOTAL 95 (100.0) 93 (100.0)
What do you think was 
the route of transmission?
Observed Agreement: 45.8% K=0.004 (p=0.96)
Contaminated solution  1 (1.1)  1 (1.1)
Hands (total) 55 (60.4) 56 (62.9)
Patient 13 (23.7a)  7 (12.5b)
HCP 34 (61.8a) 37 (66.1b)
Visitor  1 (1.8a)  0 (0.0)
(doesn´t specify)  7 (12.7a) 12 (21.4b)
Contaminated instrument 15 (16.5) 19 (21.3)
Airborne 20 (22.0) 13 (14.6)
TOTAL 91 (100.0) 89 (100.0)
What conduct should be followed 
to take care of this patient?
None in specific  0 (0.0)  2 (2.1)
Reinforce hand hygiene 68 (69.4) 61 (64.9)
Isolation of the patient (total) 98 (100.0) 84 (89.4)
Single-room isolation 13 (13.2c) 13 (15.5d)
Barrier nursing 78 (79.6c) 61 (72.6d)
Cohorting  4 (4.1c)  3 (3.6d)
(doesn´t specify)  3 (3.1c)  7 (8.3d)
Alter/ implement antibiotic 
therapy
 – (–) 66 (70.2)
TOTAL 98 (100.0) 94 (100.0)
a n=55 / b n=56 / c n=98 / d n=84.
Kappa value calculations only considered the four main options: 
contaminated solution, hands, contaminated instrument and 
airborne.
Total values exceed 100% because participants could choose more 
than one option.
Table 4 – Perception of nurses and doctors of the 
epidemiology of MRSA and measures to manage 
positive patients
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was higher than the difference found in a USA study developed 
in an acute care military facility, where MRSA patients had a 
length of stay 3.3 times higher.26
Although the mortality value we described may not be 
directly related to the mortality caused by MRSA, it may be an 
indication of the morbidity associated with this microorganism, 
as well as the susceptibility of the population it affects. For this 
indicator a 5.5 fold difference was found between the studied 
population and the general adult hospitalized population 
(27.0% versus 4.9%). Madani et al.19 described a general mortality 
of 53.7% in a population infected with MRSA, but regarded as 
mortality directly associated with this infection 36.4% of the 
cases. 
Usually an infection is considered acquired at a healthcare 
facility when it appears 48 hours after the admission.16 In this 
study 31 patients (27.9%) were identified as MRSA positive 
less than 48 hours after admission, which could lead us to 
consider a community origin. A Portuguese study27 involving 
3,266 healthy individuals from the community detected low 
prevalence of MRSA nasal colonization (0.7%). However, all but 
3 of our patients had classical risk factors for MRSA carriage: 
6 came from other acute care facilities, 4 from long term care 
facilities and 18 had a history of hospitalization during the 
previous year. 
MRSA rates in Portugal are know to be high: in 2005 the 
“European Antimicrobial Resistance Surveillance System” 
detected a proportion of resistance of 46.6% in Portugal,1 which 
is in agreement with the 47.5% of resistance reported in a 
Portuguese study involving 9 hospitals.28 Both values were 
still lower than the 60.0% detected in our study. A German 
study29 identified an average value of incidence density of 
2.77‰ in 38 ICU’s and a French multicenter study30 described a 
rise of this indicator from 0.71 to 0.96‰ between 1996 and 2000. 
Richet et al.31 studied 90 healthcare facilities around the world 
and detected median values of 0.40‰ for Western Europe and 
hospital category<500 beds. Once again the values found were 
lower than the one in our study (1.66‰).
The majority of the HCP’s had the perception that this 
MRSA strains were hospital acquired, but Kappa value 
identified just a “fair agreement” between nurses and 
doctors. A possible explanation for this would be the HCP’s 
not taking into account the 48 hour timing generally used 
to distinguish hospital from community acquired infection. 
Considering the changing epidemiology of the MRSA, Klevens 
et al.32  proposed a different classification of cases into 
three mutually exclusive groups: (a) healthcare-associated 
community-onset; (b) healthcare-associated hospital-onset 
and (c) community-associated. This is an interesting approach 
and should be considered in future research in this area. 
Nurses identified first the “environment” and then a 
“member of the staff” as the possible source (opposed to 
the doctors who chose “member of the staff” first), perhaps 
because nurses spend more time on the wards and recognize 
the limitations of the cleaning procedures. Both groups of 
HCP’s are concerned about being themselves the source of the 
MRSA, more than the option “other patient”. Bearing in mind 
that clinical microbiological cultures fail to identify up to 85% 
of MRSA-colonized patients,33 if the HCP has the perception 
that the other patients are not likely to be the source, this could 
have serious implications on the adherence to the Standard 
Precautions. 
Slightly more doctors than nurses thought the route of 
transmission was the hands of a HCP. This is an interesting 
result considering that fewer doctors chose the option 
“reinforce hand hygiene” when asked about the management of 
MRSA positive patients. It would seem that there is a difference 
between the knowledge and importance of this practice and 
its day-to-day application. One study34 recognized that 62% of 
the doctors and 72% of nurses have the perception that they 
practice hand hygiene more than 80% of the times before and 
after contact with patients, concluding that HCP’s perception 
of the compliance with infection control measures are better 
than their actual practice, as demonstrated by observational 
studies. CDC guidelines35 also indicate physician status as 
an observed risk factor for poor adherence to recommended 
hand-hygiene practices. It is interesting to  see that a 
substantial number of HCP’s identified the air as possible 
route of transmission (22% of the nurses and 14.6% of doctors). 
Although some studies36,37 suggest that MRSA is recirculated in 
the air, especially after movement, such as in bedmaking, it is 
considered that the transmission of MRSA within healthcare 
facilities primarily occurs via carriage on the hands of 
healthcare workers.11
The fact that two doctors and none of the nurses agreed 
that no specific measures were necessary to take care of MRSA 
positive patients and that 100% nurses identified the need to 
isolate these patients, in contrast with just 89.4% of the doctors, 
is in agreement with other studies. Afif et al.38 referred that 
the compliance to MRSA precautions is worse among doctors 
as compared to nurses (Odds Ratio 0.35; 95% confidence 
interval, 0.14 to 0.86). Seaton and Montazeri39 described, in a 
population of British doctors, that 10% did not agree with the 
use of gloves when examining patients with MRSA and 34% 
did not believe in the efficacy of alcohol hand rub solutions in 
reducing MRSA transmission, concluding that “there is scope 
for improvement in awareness and knowledge about MRSA 
and its management”. Acknowledging this problem, the recent 
CDC guidelines40 advise that “improvement requires that the 
organizational leadership make prevention an institutional 
priority and integrate infection control practices into the 
organization’s safety culture”. 
The high endemic values detected in our study as well 
as differences in the perception of the HCP’s about the 
epidemiology and management of MRSA positive patients 
justify the need to implement a global infection control 
programme for MRSA, with consensus-based measures for 
management of colonized and infected patients, more effective 
strategies for the rational use of antimicrobials, as well as more 
dynamic and focused educational programmes for healthcare 
professionals.
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